Harel Insurance Cuts Advanced Micro Devices Stake 2.9% to $21.7M; CEO Sells 125,000 Shares
Harel Insurance Investments sold 4,050 AMD shares in Q3, trimming its holdings by 2.9% to 134,202 shares worth $21.7 million. CEO Lisa Su sold 125,000 shares at $215.14 and EVP Mark Papermaster sold 17,108 shares at $240.12, signaling insider share reductions.
1. Q3 Earnings and Segment Momentum
In its fiscal 2025 third quarter, AMD reported non-GAAP EPS of $1.20, topping consensus estimates of $1.16, and delivered revenue of $9.25 billion versus forecasts of $8.75 billion. Data-center sales reached a record $4.3 billion, up 22% year-over-year, while client and gaming revenues rose 46% and 181% respectively to $2.9 billion and $1.3 billion. Over the past year, shares have climbed nearly 96% on the back of these strong results, with particular strength seen in Japan where gaming-chip market share has risen to 45% as the Ryzen 7 7800X3D earns top performance and power-efficiency accolades.
2. Strategic AI and Data-Center Expansion
Under CEO Dr. Lisa Su, AMD has bolstered its end-to-end AI offering through the $4.9 billion acquisition of ZT Systems, integrating cloud architecture with its MI300 GPU line for direct competition with Nvidia’s AI graphics processors. The MI300, adopted by hyperscale customers such as Microsoft and Oracle, is priced at roughly a quarter of its primary rival yet delivers comparable performance, helping to drive a 94% year-over-year jump in 2024 data-center revenue to $12.6 billion and a record 122% increase in Q3 alone.
3. Long-Term Upside and Key Risks
AMD management forecasts a 60% compound annual growth rate in data-center revenue and 35% overall revenue CAGR through 2030, supporting analyst models that envision upside of up to 348% by decade’s end. However, the stock trades at a rich multiple, suggesting much of this growth may already be priced in. Key risk factors include reliance on Taiwan Semiconductor for manufacturing amid geopolitical tensions, margin pressure against Nvidia’s faster product cycle, and U.S. export restrictions requiring development of downgraded chips for certain markets.